A Study on the Clinical, Biochemical, and Hormonal Profile of Polycystic Ovary Syndrome Patients Attending a Tertiary Care Hospital

    April 2017 in “ International journal of reproduction, contraception, obstetrics and gynecology ”
    J C Spandana, K Prasanna Kumar Shetty
    Image of study
    TLDR The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.
    Between January 2014 and July 2015, a study involving 100 patients with polycystic ovary syndrome (PCOS) was conducted to examine their clinical, biochemical, and hormonal profiles. The study found a 6.3% prevalence of PCOS among gynecology outpatients and 37.14% among infertile women. The most common symptoms were menstrual irregularity (31%) and infertility (23%), with a significant correlation between menstrual irregularities and elevated levels of luteinizing hormone (LH) and an elevated LH to follicle-stimulating hormone (FSH) ratio. Additionally, 21.3% of the participants had metabolic syndrome, with a 21-fold increased risk associated with a higher waist-hip ratio (WHR). The majority of PCOS patients were hirsute with central obesity, and either overweight or obese, with oligomenorrhea being the most common presentation. The study concluded that WHR is a significant risk factor for metabolic syndrome in PCOS patients, highlighting the importance of focused management for obese women with PCOS.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Related Research

    3 / 3 results